| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.8M | +19.7% |
| SG&A Expense | $8.5M | +15.8% |
| Operating Income | -$15.3M | -17.5% |
| Pre-tax Income | -$14.6M | -12.9% |
| Income Tax | $0 | — |
| Net Income | -$14.6M | -12.9% |
| EPS (Basic) | -$0.72 | +54.7% |
| EPS (Diluted) | -$0.72 | +54.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.2M | +350.4% |
| Current Assets | $16.8M | +316.6% |
| Total Assets | $17.1M | +324.1% |
| Total Liabilities | $1.2M | -28.3% |
| Stockholders' Equity | $15.9M | +571.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | -21.6% |
| Capital Expenditures | $256K | — |
| Investing Cash Flow | -$256K | — |
| Financing Cash Flow | $25.0M | +7041.1% |
| Free Cash Flow | -$12.3M | -24.1% |